Analytical BioSciences Sells Global Rights to Pre-Clinical Anti-Tumor Drugs to Gilead
Sino-US firm Analytical BioSciences Limited has entered into an asset purchase agreement with Gilead (NASDAQ:...
Deals
CanSino Biologics Partners with Etana for Inhaled Tuberculosis Vaccine Development
China-based CanSino Biologics (SHA: 688185, HKG: 6185) has entered into a strategic partnership with Indonesia-based...
Zhida Pharma Secures Licensing Deal for Vivesto AB’s Apealea in China
Zhejiang-based Zhida Pharma has announced a licensing deal with Sweden-headquartered Vivesto AB (STO: VIVE), securing...
Guangzhou Innogen Pharmaceutical Files for IPO on Hong Kong Stock Exchange
Guangzhou Innogen Pharmaceutical Group Co., Ltd., a China-based pharmaceutical company, has made an initial public...
Coherus BioSciences Sells Udenyca Franchise to Intas Pharmaceuticals in Asset Purchase Deal
US-based Coherus BioSciences, Inc. (Coherus, NASDAQ: CHRS) has announced an asset purchase agreement with Indian-headquartered...
GSK plc Enters Exclusive Option Agreement with Duality Biologics for ADC Candidate DB-1324
UK-based GSK plc (NYSE: GSK) has entered into an exclusive option agreement with Duality Biologics,...
Keros Therapeutics and Takeda Enter Licensing Agreement for Elritercept Development
US-based Keros Therapeutics, Inc. (NASDAQ: KROS) has announced a significant licensing agreement with Japan-headquartered Takeda...
Gilead Sciences Secures Exclusive Option for Tubulis’ Tubutecan and Alco5 Platforms to Develop ADC
US-based Gilead Sciences Inc., (NASDAQ: GILD) has announced an exclusive option and license agreement with...
Ophthalmology Biotech Cloudbreak Pharma Inc. Pursues Hong Kong IPO
Cloudbreak Pharma Inc., a Cayman Island-registered ophthalmology biotech company, has filed for an initial public...
COUR Pharmaceutical Enters Licensing Agreement with Genentech for Autoimmune Disease Treatment
US-based COUR Pharmaceutical has announced a strategic collaboration and licensing agreement with Genentech, a member...
Ipsen Secures Global Licensing Agreement for Biomunex Pharmaceuticals’ BMX-502 T Cell Engager
France-based Ipsen (OTCMKTS: IPSEY) has announced a significant global licensing agreement with compatriot firm Biomunex...
REGiMMUNE and San Fu Biotech Ink Deal for RGI-2001 Development in Asia
Taiwan-based biotechnology company REGiMMUNE Ltd has announced the signing of an out-license agreement with San...
Jiangsu Hengrui Pharmaceuticals’ Fluzoparib and Apatinib Gain NMPA Approval for Metastatic Breast Cancer Treatment
Jiangsu Hengrui Pharmaceuticals Co., Ltd. (SHA: 600276), a leading China-based pharmaceutical company, has announced that...
Fangzhou Inc. Expands Partnerships with Tencent Healthcare and Baidu Health at Digital Summit
China-based Fangzhou Inc. (HKG: 6086) hosted the “Data and AI: Decoding Digital Engagement” summit in...
MGI Tech Co., Ltd Partners with Universidad de San Martín de Porre for Genomic Sequencing Advancement
China-based gene sequencing specialist MGI Tech Co., Ltd has announced a collaboration with the Universidad...
VFLO Medical Partners with Inari Medical to Expand Access in Greater China
China-based VFLO Medical, a peripheral vascular device firm incubated by 6 Dimensions Capital, has announced...
China Medical System Holdings Secures Exclusive Rights to Atom Therapeutics’ Gout Drug ABP-671
China Medical System Holdings (CMS; HKG: 0867) has entered into a licensing agreement with compatriot...
Novartis Secures Global Rights to PTC Therapeutics’ Huntington’s Disease Treatment PTC518
Swiss pharmaceutical giant Novartis (NYSE: NVS) has entered into a global license and collaboration agreement...
UCB Partners with BioRay Biopharmaceutical for Bimzelx Commercial Promotion in China
Belgium based UCB (EBR: UCB) is fulfilling its commitment to enhance attention to innovative products...
CBC Group and Mubadala Acquire UCB’s Neurology and Allergy Business in China for $680 Million
Singapore-based healthcare private equity firm CBC Group and Mubadala Investment Company, a global investment company...